-The Indian Express The government will be analysing mortality figures during drug trials in India following WHO data showing that 2,031 people died between 2008 and 2011 in such trials in the country. That amounts to about 10 people per week, or more than one person a day. At the same time, the data shows that only 1.5 per cent of clinical trials held across the world so far (2,770 of 1,76,641)...

-Inclusion.in There is good news. And there’s bad news. The good news first. There’s been a bumper wheat crop and the granaries are overflowing. And the bad news? Where do we begin? A lot of that grain will rot. Millions will still remain hungry. Heavily in debt and distressed, farmers are committing suicide. Food prices are soaring. There’s more… Farmers don’t have money. Their land is too small and isn’t yielding much. Fertilisers and...

Act makes it possible to seize and destroy even legitimately produced generic drugs exported from India to poor countries It was a triumphant moment for public health campaigners when members of the European Parliament voted against the Anti- Counterfeiting Trade Agreement (ACTA) on July 4. ACTA is a plurilateral pact, designed to protect against counterfeiting of products, including medicines. ACTA, primarily drafted and secretly negotiated by the US, was signed on October...

-The Hindu State says Constitution does not allow government spending for religious bodies The Supreme Court has declined to stay, at this stage, the Gujarat High Court order directing the State government to pay compensation to more than 500 shrines damaged during the 2002 riots. Earlier, appearing for the Gujarat government before Justices K.S. Radhakrishnan and Dipak Misra, Additional Advocate-General Tushar Mehta and counsel Hemantika Wahi argued that under the Constitution, there could...

Regulations covering public health should override personal rights and the country cannot wait any more for a good public health law. The health care industry, including institutions of medical education, hospitals and pharmaceutical businesses, have grown into behemoths that can do considerable harm in the absence of independent and effective regulatory systems. While there are no success stories in the regulation of any kind of industry in India, I will focus...